An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Nature Medicine2014Vol. 20(5), pp. 548–554
Citations Over TimeTop 1% of 2014 papers
Aaron M. Newman, Scott V. Bratman, Jacqueline To, Jacob Wynne, Neville Eclov, L.A. Modlin, Chih Long Liu, Joel W. Neal, Heather A. Wakelee, Robert E. Merritt, Joseph B. Shrager, Billy W. Loo, Ash A. Alizadeh, Maximilian Diehn
Related Papers
- → Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility(2015)350 cited
- → Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management(2018)348 cited
- → Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons(2016)68 cited
- The role of circulating tumor DNA in evaluating minimal residual disease in luminal gastrointestinal malignancies.(2022)
- → [Research progress on circulating tumor DNA as a biomarker for minimal residual disease in solid tumors].(2023)1 cited